Maharashtra: MLA hostel canteen licence suspended after Shiv Sena MLA assaults staff over ‘stale food'
'….the license granted to your establishment from date 26-06-2024 to legal validity date 27-09-2027 is being suspended with immediate effect. You are further informed that during the license suspension period mentioned in the attached order, you or anyone on your behalf should not buy, sell or distribute food items, if found doing so, you should note that legal action will be taken against you for selling/distributing food items without a valid license as per the provisions of the Food Safety and Standards Act 2006 and the rules/regulations there under,'the order issued on Wednesday by the FDA said.
As a purported video of the assault by Gaikwad surfaced on social media, Gaikwad came under the fire by the the Opposition leader as they raised the matter in the Legislative Council and sought his suspension.
Maharashtra Chief Minister Devendra Fadnavis said Gaikwad's behaviour had tarnished the image of the Legislature, and the Assembly Speaker and Legislative Council Chairman should decide on action against him. Saying that elected representatives should behave 'responsibly', Gaikwad's party leader and Deputy Chief Minister Eknath Shinde said he had reprimanded the MLA.
Meet Shah Sena's MLA Sanjay Gaikwad. Last year he had threatened&announced 11 lakh rupees to anyone who cuts off Sh. Rahul Gandhi's tongue. Now the man is seen beating up a poor helpless canteen worker. But wait no news TV outrage here since its a BJP ally pic.twitter.com/XVwnEzJFSU
— Priyanka Chaturvedi🇮🇳 (@priyankac19) July 9, 2025
In the purported video clip of the incident, Gaikwad, wearing a towel and a vest, is seen confronting the canteen staff over what he claimed was sour dal and spoiled rice. He then repeatedly assaults a canteen employee and tells others not to pay their bills. His supporters, too, are seen assaulting the canteen workers.
No police complaint was filed till evening. However the FDA was immediately swing into the action and conducted the inspection at the canteen.
The slueth of FDA collected samples of food from the MLAs' Hostel canteen and sent them for testing. 'The team collected samples of food like paneer, sauces and dal. These will be sent to the laboratory; the reports are expected in 14 days,' an FDA official said.
However soonafter that, the FDA issued a suspension order to the Ajanta Caterer, the private contractor who runs the canteen under the supervision of the Legislature Secretariat.
Speaking to reporters on Wednesday, Gaikwad claimed that was served stale food in his room. He said he had complained about the quality of food earlier, but no action was taken. 'If such food is being served to an MLA, imagine what the common man must be getting,' said the MLA, who represents Buldhana Assembly constituency.
'I have no regrets over what I did. I am a public representative… when someone fails to understand democratic language, then I have to use this language. I had complained to the authorities on several occasions. I don't regret it and I will repeat it if needed,' he said.
'I had complained about the poor quality of food two or three times. This time, the food was absolutely unacceptable… completely spoiled. I will raise this issue in the ongoing Legislative session,' he said. He also met Assembly Speaker Rahul Narvekar to complain about the quality of food.
'People from all across the state come here; workers and officials come here to eat. The quality of food should be good here as it is a government canteen,' Gaikwad said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
10 hours ago
- Time of India
Personal Law Board vice-president demands condemnation of Varsha Gaikwad's statement on 2006 Mumbai train blasts verdict
MUMBAI: All India Muslim Personal Law Board ( ) vice-President Maulana Obaidullah Khan Azmi has launched a scathing attack on Mumbai Congress President and MP Varsha Gaikwad over her response to the 2006 Bombay train blasts acquittals. Tired of too many ads? go ad free now In a strongly-worded letter, addressed to the Leader of Opposition Rahul Gandhi, Congress President Mallikarjun Kharge and General Secretary K.C. Venugopal, ormer Rajya Sabha member Azmi has demanded immediate condemnation of Gaikwad's statements as it exposes deep tensions with the party's traditional Muslim voter base. Azmi, an influential figure in Muslim politics who served in Parliament from 1990 to 2008, accused Gaikwad of undermining the Congress's secular credentials by demanding an appeal in the Supreme Court against acquittals of the 12 accused by the Bombay High Court in the 2006 train bombings case. The comprehensive 671-page judgment acquitted all 12 accused after 19 years of legal proceedings, citing the prosecution's complete failure to prove the case beyond reasonable doubt. The court delivered severe criticism of the original investigation, highlighting systemic incompetence, procedural lapses, and allegations of torture used to extract confessions, despite police submitting a massive 44,500-page charge sheet related to the July 11, 2006 attacks that killed over 180 people and injured more than 800 in seven coordinated train bombings. The AIMPLB leader characterized Gaikwad's call for an appeal as "heartless" and reminiscent of "RSS-like ideologies," marking a significant escalation in intra-party conflict. He specifically targeted what he perceives as her "betrayal" of the Muslim community, noting her political career thrived on "unwavering Muslim support." Azmi argued that, instead of advocating for compassion or compensation for families who endured 19 years of wrongful imprisonment, Gaikwad aligned herself with "divisive narratives" that contradict Congress's commitment to fairness. Tired of too many ads? go ad free now His letter warned that this stance risks alienating a vital electoral base, potentially forcing Muslim supporters to reconsider their trust in Congress leadership. The controversy erupted after Gaikwad publicly stated "all Mumbaikars feel deeply betrayed" by the acquittals and urged the state government to "put all its legal might" into challenging the verdict in the Supreme Court to deliver justice to victims' families. These remarks drew immediate backlash from Muslim leaders who viewed them as a profound betrayal. The political fallout intensified when the Supreme Court stayed the Bombay High Court verdict on July 24, 2025, though clarifying the acquitted individuals wouldn't return to prison. This intervention followed the Maharashtra government's appeal, with Solicitor General Tushar Mehta expressing concern the verdict's observations could impact other cases under the Maharashtra Control of Organised Crime Act (MCOCA). Facing mounting criticism, Gaikwad later clarified her words were misconstrued, emphasizing her commitment to constitutional principles as a follower of B.R. Ambedkar. She stated she had questioned the government about compensation for the wrong fully imprisoned while also seeking justice for blast victims' families. However, sections of Muslim leaders remained unconvinced, arguing the damage was already done. Azmi's letter reflects broader concerns about the 's commitment to secular principles and its ability to maintain minority trust in a polarized climate. The veteran politician warned that failure to address these issues could further erode the party's credibility and moral foundation, with senior leadership's response likely determining whether crucial Muslim voter support can be retained in future elections.
NDTV
14 hours ago
- NDTV
US FDA Vaccine Chief Vinay Prasad Leaves Agency 3 Months After Appointment
Washington: The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech executives, patient groups and conservative allies of President Donald Trump. Dr. Vinay Prasad 'did not want to be a distraction' and was stepping down from his role as the FDA's top vaccine regulator 'to spend more time with his family,' a spokesperson for the Department of Health and Human Services said in a statement late Tuesday. Two people familiar with the situation told The Associated Press that Prasad was ousted following several recent controversies. They spoke on condition of anonymity to discuss internal personnel matters. Prasad did not immediately respond to requests for comment Wednesday morning. FDA's drug center director, Dr. George Tidmarsh, will take over Prasad's job in an acting role, according to an agency email shared with the AP. Tidmarsh started at the FDA last week after a decades-long career as a pharmaceutical executive and adjunct professor. Prasad joined the FDA in May from the University of California San Francisco, where he frequently criticized the FDA's approach to drug approvals and COVID-19 vaccines. His contrarian approach appeared to match that of his boss FDA Commissioner Marty Makary, who repeatedly praised Prasad's work and intellect. But in recent weeks Prasad became a target of right-wing activists, including Laura Loomer, who flagged Prasad's past statements criticizing Trump and praising liberal independent Senator Bernie Sanders. 'How did this Trump-hating Bernie Bro get into the Trump admin???' Loomer posted on X last week. Trump previously fired several national security officials a day after Loomer raised concerns about their loyalty. Prasad also attracted scrutiny for his handling of a recent safety issue surrounding the only approved gene therapy for Duchenne's muscular dystrophy. Under his direction, shipments of the therapy were briefly halted after a series of patient deaths, then resumed late Monday following vocal pushback from families of boys with the fatal muscle-wasting disorder. Prasad has long been skeptical of the therapy and other muscular dystrophy drugs sold by the drugmaker, Sarepta Therapeutics. As an academic, Prasad gained prominence by attacking the FDA for being too lenient in its standards for approving cancer drugs and other new therapies. That approach is at odds with Trump's Republican supporters, who generally favor speedier approvals and unfettered access to experimental treatments. During Trump's first term he signed the ' Right to Try ' law, a largely symbolic piece of legislation that won popular support from conservatives seeking to give terminal patients expanded access to unproven drugs. Prasad's decision to pause Sarepta's therapy was criticized last week by a columnist and the editorial board of The Wall Street Journal. Separately, Prasad's division issued three rejection letters this month to small biotech firms seeking approval for new gene therapies. Those drugs have been vigorously embraced by many of the anti-abortion groups in Trump's base for their potential to address intractable diseases that sometimes lead parents to terminate pregnancies. Prasad's predecessor in at FDA, Dr. Peter Marks, oversaw a dramatic rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of patients' genetic code. Prasad has been an outspoken critic of Marks' leadership at FDA, which included overseeing the approval of the first COVID vaccines and therapies.
India Today
a day ago
- India Today
What forced Vinay Prasad to exit top job at US FDA in just 3 months
The US Food and Drug Administration's (FDA) top vaccine official, Vinay Prasad, stepped down in less than three months after his appointment, following intense scrutiny over his regulatory decisions and political attacks from conservative activists. His stringent oversight of biopharmaceutical company Sarepta Therapeutics' gene therapy for Duchenne Muscular Dystrophy (DMD), a severe genetic disorder, sparked backlash from patient groups and investors, while his approach also raised concerns among biotech firms about innovation, clashing with FDA priorities, according to reports in US-based media an oncologist who was a fierce critic of the US COVID-19 vaccine and mask mandates, was appointed in May by FDA Commissioner Marty Makary. Together, they promised to speed regulatory action and pilot new review pathways, news agency Reuters he faced mounting scrutiny over his decision to pause shipments of Sarepta's Elevidys, a gene therapy for DMD, after three patient deaths raised safety concerns, Reuters reported. The FDA, on July 18, asked Sarepta to stop all shipments of the approved DMD therapy, citing safety FDA's decision to halt shipments sparked outrage from patient groups and biotech investors, who argued the therapy's benefits for a fatal disease were July 28, the FDA reversed course, allowing shipments to resume for ambulatory regulatory approach and the absence of clearly defined standards prompted concern within parts of the biotech industry, with some suggesting it could impact investment and innovation – raising questions about alignment with Marty Makary's priorities, according to an op-ed in the Wall Street Journal (WSJ).The agency's lack of clear, predictable standards under Prasad was creating enormous uncertainty for the industry, especially small biotech companies, and threatened to chill investment, according to the inflexible position on the design of clinical trials also risked slowing and raising costs for drug development. This is the opposite of what Marty Makary says he wants to do, the WSJ op-ed Republican Senator Rick Santorum, who has connections to Sarepta Therapeutics, reportedly contacted senior White House officials to express concerns over Prasad's attempts to restrict the use of Elevidys, Daily Beast reported, citing The has maintained that its treatment was not responsible for the reported deaths. Prior to joining the FDA, Dr Prasad had voiced criticism of the company, and following his appointment, Sarepta's stock dropped by nearly 25%, according to people familiar with the situation told the Associated Press (AP) that Prasad was ousted following several recent joined the FDA in May after years as an academic researcher at the University of California, San Francisco, where he frequently criticised the FDA's approach to drug approvals and Covid-19 vaccines, AP PRASAD RESIGNS TO AVOID DISTRACTIONA Department of Health and Human Services spokesperson told CNN on July 29 that Vinay Prasad resigned to avoid being a "distraction" to the agency's work under the Trump administration, choosing to return to California to spend more time with his Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family," the spokesperson told the Prasad was also given the role of FDA chief medical and scientific several health officials later appointed under the Trump administration, Prasad had previously been outspoken in his criticism of the government's handling of the Covid-19 pandemic and its vaccine departure came amid fresh pressure from the White House for him to resign, according to a person familiar with the matter who was granted anonymity to describe the internal dynamics, and followed days of criticism from Laura Loomer, a right-wing activist with extraordinary access to President Donald Trump, CNN July 20, Loomer, a close Trump supporter, published a blog post accusing Prasad of being a "progressive leftist saboteur" and claiming he was actively working against the mission of the former administration officials and advisers, from campaign strategists to public health voices, faced public targeting by Loomer before being sidelined or dismissed by who called herself an investigative journalist, has built a reputation for aggressive rhetoric, confrontational tactics, and a social media presence that thrives on Loomer has no formal role in Donald Trump's campaign or political machinery, her influence seems to travel in parallel with the MAGA ecosystem. Several former administration officials and advisers – ranging from campaign strategists to public health voices – have found themselves publicly targeted by Loomer shortly before being sidelined or dismissed by Trump or his inner days before his resignation, the FDA Commissioner publicly defended Prasad, telling Politico that he is "an impeccable scientist" and "one of the greatest scientific minds of our generation."Prasad also drew criticism from former officials and vaccine experts after internal memos from May revealed that he overrode FDA scientists on recommendations for two new versions of COVID-19 vaccines, CNN reported.- EndsMust Watch
